GlassScriptPhysician profile
Remo L Morelli
NPI 1932240595
$18,107.05
in general payments reported to CMS, 2019-2025
48 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,474 · 2020: $3,476 · 2021: $2,615 · 2022: $2,612 · 2023: $2,340 · 2024: $1,484 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,929.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,246.17 | 2019-2020 | |
| Boston Scientific Corporation | $1,770.42 | 2019-2025 | Watchman Flx |
| Amgen INC. | $1,237.02 | 2019-2025 | Repatha |
| Esperion Therapeutics, INC. | $1,227.05 | 2020-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $1,131.46 | 2019-2025 | |
| Novo Nordisk INC | $917.47 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $915.95 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $836.15 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $778.31 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $741.94 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $595.85 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $514.50 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $508.17 | 2021-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $485.36 | 2019-2025 | Cardiomems, Gallant, Jot Dx |
| Sanofi-Aventis U.S. LLC | $470.94 | 2019-2024 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $454.26 | 2020-2022 | |
| Irhythm Technologies, INC. | $392.77 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $320.00 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $315.86 | 2019-2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $276.79 | 2019-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $196.43 | 2024 | Arcalyst |
| Medtronic, INC. | $185.17 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $181.70 | 2022-2023 | Optimizer |
| Chiesi USA, INC. | $168.13 | 2021-2024 | Cleviprex, Kengreal |
| Kiniksa Pharmaceuticals, LTD. | $156.55 | 2021-2023 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $121.02 | 2021-2022 | |
| Edwards Lifesciences Corporation | $87.85 | 2020-2022 | |
| Lundbeck LLC | $87.23 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $83.95 | 2023-2024 | Inpefa |
| Abiomed | $82.44 | 2021 | |
| Astellas Pharma US INC | $72.70 | 2020-2021 | |
| Elutia, INC. | $72.49 | 2019 | |
| Cathworks, INC. | $55.98 | 2020-2022 | |
| Scpharmaceuticals INC. | $45.84 | 2023-2025 | |
| Philips North America LLC | $44.55 | 2024 | (5044) Mcot |
| Baxter Healthcare | $43.14 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Shockwave Medical, INC | $42.39 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $36.96 | 2024 | |
| Alnylam Pharmaceuticals INC. | $28.53 | 2025 | Amvuttra |
| Avinger INC. | $24.79 | 2019 | |
| Arbor Pharmaceuticals, INC. | $23.18 | 2022 | |
| Inari Medical, INC. | $21.87 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teva Pharmaceuticals USA, INC. | $20.98 | 2021 | |
| Agepha Pharma Fz LLC | $19.54 | 2025 | Lodoco |
| Sandoz INC. | $18.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.34 | 2019 | |
| Heartflow, INC. | $16.04 | 2019 | |
| Cardiovascular Systems INC. | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Remo Morelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.